PRELUDE CAPITAL MANAGEMENT, LLC - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$53,000
+65.6%
80,400
-21.7%
0.01%
+25.0%
Q4 2016$32,000
+128.6%
102,700
+219.9%
0.00%
+300.0%
Q3 2016$14,000
+600.0%
32,100
+453.4%
0.00%
Q2 2016$2,0005,8000.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
BAXTER BROS INC 148,006$206,0000.10%
First Heartland Consultants, Inc. 86,204$120,0000.07%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 671,900$934,0000.02%
Investors Capital Advisory Services 47,238$65,0000.02%
PINNACLE FINANCIAL PARTNERS INC 20,000$28,0000.01%
Commonwealth Equity Services, Inc 481,140$669,0000.01%
REYNOLDS CAPITAL MANAGEMENT LLC 11,300$16,0000.01%
First Allied Advisory Services, Inc. 50,000$70,0000.01%
Winslow, Evans & Crocker, Inc. 13,200$18,0000.01%
AMALGAMATED BANK 16,650$23,0000.00%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders